Journal for ImmunoTherapy of Cancer (Nov 2021)
898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models
Abstract
No abstracts available.